Beth Fernandes: Bringing Alaska’s First Civilian Medevac Whole Blood Program To Life
Beth Fernandes, Clinical Director at Aircare Alaska, shared a post on LinkedIn:
“Meet the women, I am so proud to work alongside, who brought Alaska’s first civilian medevac whole blood program to life.
This wasn’t a single initiative—it was a coordinated effort across clinical care, blood banking, and logistics to solve one problem: how to deliver the right resuscitation, at the right time, in one of the most remote and challenging environments in the world.
Why who
Because timing matters. In hemorrhagic shock, early, balanced resuscitation iscal—and whole blood allows us to bring that capability closer to the point of injury, rather than waiting hours for definitive care.
What the evidence shows:
- Early use of whole blood is associated with improved survival, particularly in trauma patients with hemorrhagic shock
- Whole blood provides balanced resuscitation (RBCs, plasma, and platelets) in a single product—mirroring what the patient is losing
- Studies demonstrate reduced total blood product utilization compared to component therapy
- Prehospital and military data consistently support earlier correction of coagulopathy and improved hemodynamics when whole blood is used closer to the time of injury
- Simplified logistics in austere environments: one product, faster delivery, fewer delays
This program exists because of true collaboration:
Dana Rich – Delta Development Team, Inc.
Driving the operational and logistical framework that makes prehospital storage and transport possible in extreme environments
Shelina – Blood Bank of Alaska
Ensuring clinical integrity, regulatory compliance, and safe blood product management—critical to making this sustainable
And myself – AirCare Alaska
Leading clinical implementation, training, and program development to bring whole blood directly to patients in the field
Together, we played a pivotal role in delivering Alaska’s first unit of prehospital whole blood—not just as a milestone, but as a shift in how we approach rural and remote trauma care.
To me, this is what advancing care looks like:
Bringing hospital-level interventions to the patient – when and where it matters most.”

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments
-
Nov 16, 2026, 12:44Stefan Prendić: How Intronic Variants Affect Rh Blood Group Antigen Expression
-
Nov 16, 2026, 12:26Samwel Mikaye: Understanding Warfarin and Its Clinical Management
-
Nov 16, 2026, 12:14Sophia Delicou: Ensuring Lifelong Health Beyond Stem Cell Transplantation
-
Nov 16, 2026, 12:06Edward Lee Carter: Has PEPPER Changed the Role of Aspirin in Arthroplasty VTE Prophylaxis?
-
Nov 16, 2026, 11:53Eduardo Ortiz Bello: The Endothelium in Hemostasis and Microcirculation
-
Nov 16, 2026, 11:51Phil Spinella: Advancing Transfusion Medicine Through Collaboration